Emergency departmentinitiated oral naltrexone for patients with moderate to severe alcohol use disorder: A pilot feasibility study
Retrieved from Saavedra, R., Ramirez, B., & Jay, B
lower extremities, 3.4-fold
inhibited the growth of breast cancer cells in a 3D culture model, indicating that -defensin derivatives have anticancer potential 410
One year after the start of the treatment, researchers found that the average weight reduction was 3.6% among the participants who discontinued their treatment early, compared to 6.8% for those who discontinued their treatment late
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjth TV, Manning LS, Pi-Sunyer X, SCALE Obesity Prediabetes NN8022-1839 Study Group (2017) 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial